Gingival Recession
Conditions
Keywords
gum, recession
Brief summary
The purpose of this observational research study is to understand more about wound healing of gum tissue. This study was the biomarker study of a small cohort of study participants derived from NCT01547962 (completed). Two surgical sites of each patient were randomly selected to receive CelTx™ as a donor material in one site and conventional autograft using keratinized tissue from the palate as the donor material at the contralateral (opposite side) site. Fluids collected from between a tooth and the gum and directly from wounds contain proteins that occur in different levels as the wound healing process proceeds. In this research study wound fluid will be collected from the donor palate site (roof of your mouth) and the treated sites on your gum before and after placement of CelTx and conventional treatment (tissue from the roof of your mouth) to measure which proteins and how much of each are present during the first 4 weeks of wound healing.
Detailed description
In a clinical trial designed to evaluate the safety and effectiveness of rhPDGF-BB to promote soft and hard tissue engineering of the periodontium, the subjects provided gingival crevicular fluid (GCF) or periodontal wound fluid (WF) and the results demonstrated contrasting inducible expression patterns of PDGF-AB, VEGF, and ICTP during periodontal healing \[17, 24, 25\]. However, little is known regarding the release of these molecules into local periodontal wound fluid during tissue-engineered grafts. The aim of this study is to determine the presence and influence of angiogenic biomarkers, such as PDGF, VEGF, and FGF, involved in the wound healing process of tissue engineered grafts in the treatment of subjects (with recession-type defects) who have an insufficient zone of attached gingival associated with at least two nonadjacent teeth. STUDY OBJECTIVES The purpose of this pilot study is to compare the expression of angiogenic biomarkers involved in the wound healing process of 2 different periodontal surgical approaches: 1) CelTx™ (living bilayered cell therapy product) and 2) free gingival grafts
Interventions
CelTx™ is a living bilayered cell therapy product. CelTx™ is constructed of Type I bovine collagen (extracted from bovine tendons and subsequently purified) and viable allogeneic human fibroblasts and keratinocytes isolated from human neonatal foreskin. This is applied once in the oral cavity.
Harvested tissue from palate
Sponsors
Study design
Eligibility
Inclusion criteria
* Subject has signed informed consent to participate in Organogenesis Clinical Protocol 06-PER-002-CTX. * Subject has signed informed consent to participate in this adjunct bio-marker study. * Subject is willing to comply with the additional study visits at weeks 2 and 3 as required by this study.
Exclusion criteria
\- Subject requires antibiotic prophylaxis for routine dental procedures.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Differences in Angiogenic Biomarkers | 5 time-points: pre-surgical, week(s) 1, 2, 3 and 4 | Within-subject difference between the concentrations at the CelTX and Free Gingival Graft areas |
| Differences in Angiogenic Biomarkers: PDGF-BB | 5 time-points: pre-surgical, week(s) 1, 2, 3 and 4 | Within-subject difference between the concentrations at the CelTX and Free Gingival Graft areas |
Countries
United States
Participant flow
Recruitment details
44 subjects were enrolled. All 44 subjects participated in both arms/groups for a total of 88 surgical sites. 2 surgical sites of each patient were randomly selected to receive LCC as a donor material in 1 site and a conventional autograft using keratinized tissue from the palate as the donor material at the contralateral site.
Participants by arm
| Arm | Count |
|---|---|
| CelTx™ & Free Gingival Grafts CelTx™: Living bilayered cell therapy product Free Gingival Grafts: Harvested tissue from palate | 44 |
| CelTx™ & Free Gingival Grafts CelTx™: Living bilayered cell therapy product Free Gingival Grafts: Harvested tissue from palate | 88 |
| Total | 132 |
Baseline characteristics
| Characteristic | CelTx™ & Free Gingival Grafts |
|---|---|
| Age, Continuous | 47.1 years STANDARD_DEVIATION 13.1 |
| Region of Enrollment United States | 44 Participants |
| Sex: Female, Male Female | 19 Participants |
| Sex: Female, Male Male | 25 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 44 | 0 / 44 |
| serious Total, serious adverse events | 0 / 44 | 0 / 44 |
Outcome results
Differences in Angiogenic Biomarkers
Within-subject difference between the concentrations at the CelTX and Free Gingival Graft areas
Time frame: 5 time-points: pre-surgical, week(s) 1, 2, 3 and 4
Population: 44 subjects were enrolled. All 44 subjects participated in both arms/groups for a total of 88 surgical sites. 2 surgical sites of each patient were randomly selected to receive LCC as a donor material in 1 site and a conventional autograft using keratinized tissue from the palate as the donor material at the contralateral site.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CelTx™ | Differences in Angiogenic Biomarkers | VEGF-pre-surgical | 0.51 ng/mL | Standard Error 0.07 |
| CelTx™ | Differences in Angiogenic Biomarkers | VGEF-week 1 | 1.04 ng/mL | Standard Error 0.24 |
| CelTx™ | Differences in Angiogenic Biomarkers | VGEF-week 2 | .28 ng/mL | Standard Error 0.06 |
| CelTx™ | Differences in Angiogenic Biomarkers | VGEF-week 3 | .14 ng/mL | Standard Error 0.03 |
| CelTx™ | Differences in Angiogenic Biomarkers | VGEF-week 4 | .1 ng/mL | Standard Error 0.02 |
| CelTx™ | Differences in Angiogenic Biomarkers | Angiogenin (ANG)-pre-surgical | 6.19 ng/mL | Standard Error 0.97 |
| CelTx™ | Differences in Angiogenic Biomarkers | Angiogenin (ANG)-week 1 | 8.32 ng/mL | Standard Error 1.26 |
| CelTx™ | Differences in Angiogenic Biomarkers | Angiogenin (ANG)-week 2 | 3.67 ng/mL | Standard Error 0.65 |
| CelTx™ | Differences in Angiogenic Biomarkers | Angiogenin (ANG)-week 3 | 1.92 ng/mL | Standard Error 0.3 |
| CelTx™ | Differences in Angiogenic Biomarkers | Angiogenin (ANG)-week 4 | 1.34 ng/mL | Standard Error 0.23 |
| CelTx™ | Differences in Angiogenic Biomarkers | IL-8-pre-surgical | 1.29 ng/mL | Standard Error 0.21 |
| CelTx™ | Differences in Angiogenic Biomarkers | IL-8-week 1 | 5.6 ng/mL | Standard Error 0.76 |
| CelTx™ | Differences in Angiogenic Biomarkers | IL-8-week 2 | .58 ng/mL | Standard Error 0.15 |
| CelTx™ | Differences in Angiogenic Biomarkers | IL-8-week 3 | .19 ng/mL | Standard Error 0.07 |
| CelTx™ | Differences in Angiogenic Biomarkers | IL-8-week 4 | .11 ng/mL | Standard Error 0.03 |
| CelTx™ | Differences in Angiogenic Biomarkers | FGF-2-pre-surgical | .65 ng/mL | Standard Error 0.12 |
| CelTx™ | Differences in Angiogenic Biomarkers | FGF-2-week 1 | 1.36 ng/mL | Standard Error 0.51 |
| CelTx™ | Differences in Angiogenic Biomarkers | FGF-2-week 2 | .4 ng/mL | Standard Error 0.11 |
| CelTx™ | Differences in Angiogenic Biomarkers | FGF-2-week 3 | .20 ng/mL | Standard Error 0.06 |
| CelTx™ | Differences in Angiogenic Biomarkers | FGF-2-week 4 | .18 ng/mL | Standard Error 0.07 |
| CelTx™ | Differences in Angiogenic Biomarkers | Angiostatin (ANT)-pre-surgical | 6728.08 ng/mL | Standard Error 1996.62 |
| CelTx™ | Differences in Angiogenic Biomarkers | Angiostatin (ANT)-week 1 | 12330.29 ng/mL | Standard Error 3523.17 |
| CelTx™ | Differences in Angiogenic Biomarkers | Angiostatin (ANT)-week 2 | 3059.87 ng/mL | Standard Error 1037.32 |
| CelTx™ | Differences in Angiogenic Biomarkers | Angiostatin (ANT)-week 3 | 1668.22 ng/mL | Standard Error 605.07 |
| CelTx™ | Differences in Angiogenic Biomarkers | Angiostatin (ANT)-week 4 | 1527.26 ng/mL | Standard Error 507.75 |
| CelTx™ | Differences in Angiogenic Biomarkers | TIMP-1-pre-surgical | 9.14 ng/mL | Standard Error 1.09 |
| CelTx™ | Differences in Angiogenic Biomarkers | TIMP-1-week 1 | 16.63 ng/mL | Standard Error 1.68 |
| CelTx™ | Differences in Angiogenic Biomarkers | TIMP-1-week 2 | 7.81 ng/mL | Standard Error 1.42 |
| CelTx™ | Differences in Angiogenic Biomarkers | TIMP-1-week 3 | 4.63 ng/mL | Standard Error 0.94 |
| CelTx™ | Differences in Angiogenic Biomarkers | TIMP-1-week 4 | 3.98 ng/mL | Standard Error 0.72 |
| CelTx™ | Differences in Angiogenic Biomarkers | TIMP-2-pre-surgical | 6.85 ng/mL | Standard Error 1.51 |
| CelTx™ | Differences in Angiogenic Biomarkers | TIMP-2-week 1 | 17.13 ng/mL | Standard Error 3.47 |
| CelTx™ | Differences in Angiogenic Biomarkers | TIMP-2-week 2 | 3.70 ng/mL | Standard Error 0.95 |
| CelTx™ | Differences in Angiogenic Biomarkers | TIMP-2-week 3 | 2.16 ng/mL | Standard Error 0.7 |
| CelTx™ | Differences in Angiogenic Biomarkers | TIMP-2-week 4 | 1.50 ng/mL | Standard Error 0.52 |
| CelTx™ | Differences in Angiogenic Biomarkers | GM-CSF-pre-surgical | 59.48 ng/mL | Standard Error 19.53 |
| CelTx™ | Differences in Angiogenic Biomarkers | GM-CSF-week 1 | 99.85 ng/mL | Standard Error 21.57 |
| CelTx™ | Differences in Angiogenic Biomarkers | GM-CSF-week 2 | 93.20 ng/mL | Standard Error 21.38 |
| CelTx™ | Differences in Angiogenic Biomarkers | GM-CSF-week 3 | 91.16 ng/mL | Standard Error 20.76 |
| CelTx™ | Differences in Angiogenic Biomarkers | GM-CSF-week 4 | 71.81 ng/mL | Standard Error 16.76 |
| CelTx™ | Differences in Angiogenic Biomarkers | IP-10-pre-surgical | .78 ng/mL | Standard Error 0.36 |
| CelTx™ | Differences in Angiogenic Biomarkers | IP-10-week 1 | .03 ng/mL | Standard Error 0.02 |
| CelTx™ | Differences in Angiogenic Biomarkers | IP-10-week 2 | .39 ng/mL | Standard Error 0.29 |
| CelTx™ | Differences in Angiogenic Biomarkers | IP-10-week 3 | .18 ng/mL | Standard Error 0.12 |
| CelTx™ | Differences in Angiogenic Biomarkers | IP-10-week 4 | .01 ng/mL | Standard Error 0.01 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | Angiostatin (ANT)-week 2 | 1524.59 ng/mL | Standard Error 654.12 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | VEGF-pre-surgical | .69 ng/mL | Standard Error 0.15 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | GM-CSF-week 4 | 80.34 ng/mL | Standard Error 16.12 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | VGEF-week 1 | .67 ng/mL | Standard Error 0.12 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | Angiostatin (ANT)-week 3 | 1682.54 ng/mL | Standard Error 453.33 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | VGEF-week 2 | .16 ng/mL | Standard Error 0.04 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | TIMP-2-week 4 | .93 ng/mL | Standard Error 0.34 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | VGEF-week 3 | .11 ng/mL | Standard Error 0.03 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | Angiostatin (ANT)-week 4 | 1183.51 ng/mL | Standard Error 441.75 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | VGEF-week 4 | .06 ng/mL | Standard Error 0.02 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | IP-10-week 2 | .08 ng/mL | Standard Error 0.08 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | Angiogenin (ANG)-pre-surgical | 5.60 ng/mL | Standard Error 0.82 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | TIMP-1-pre-surgical | 8.56 ng/mL | Standard Error 1.25 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | Angiogenin (ANG)-week 1 | 7.09 ng/mL | Standard Error 1.24 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | GM-CSF-pre-surgical | 50.27 ng/mL | Standard Error 13.97 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | Angiogenin (ANG)-week 2 | 2.56 ng/mL | Standard Error 0.54 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | TIMP-1-week 1 | 14.68 ng/mL | Standard Error 1.77 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | Angiogenin (ANG)-week 3 | 1.85 ng/mL | Standard Error 0.36 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | IP-10-pre-surgical | .21 ng/mL | Standard Error 0.07 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | Angiogenin (ANG)-week 4 | 1.58 ng/mL | Standard Error 0.38 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | TIMP-1-week 2 | 5.60 ng/mL | Standard Error 0.93 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | IL-8-pre-surgical | 1.31 ng/mL | Standard Error 0.22 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | GM-CSF-week 1 | 102.02 ng/mL | Standard Error 24.65 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | IL-8-week 1 | 4.44 ng/mL | Standard Error 0.72 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | TIMP-1-week 3 | 3.98 ng/mL | Standard Error 0.77 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | IL-8-week 2 | .31 ng/mL | Standard Error 0.09 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | IP-10-week 4 | .01 ng/mL | Standard Error 0.01 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | IL-8-week 3 | .15 ng/mL | Standard Error 0.06 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | TIMP-1-week 4 | 3.58 ng/mL | Standard Error 0.73 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | IL-8-week 4 | .11 ng/mL | Standard Error 0.04 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | GM-CSF-week 2 | 93.81 ng/mL | Standard Error 20.36 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | FGF-2-pre-surgical | .72 ng/mL | Standard Error 0.17 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | TIMP-2-pre-surgical | 11.11 ng/mL | Standard Error 4.18 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | FGF-2-week 1 | .85 ng/mL | Standard Error 0.17 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | IP-10-week 1 | .5 ng/mL | Standard Error 0.45 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | FGF-2-week 2 | .34 ng/mL | Standard Error 0.11 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | TIMP-2-week 1 | 9.91 ng/mL | Standard Error 2.14 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | FGF-2-week 3 | .29 ng/mL | Standard Error 0.08 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | GM-CSF-week 3 | 86.16 ng/mL | Standard Error 18.34 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | FGF-2-week 4 | .24 ng/mL | Standard Error 0.08 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | TIMP-2-week 2 | 2.41 ng/mL | Standard Error 0.77 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | Angiostatin (ANT)-pre-surgical | 7931.32 ng/mL | Standard Error 2813.77 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | IP-10-week 3 | .02 ng/mL | Standard Error 0.01 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | Angiostatin (ANT)-week 1 | 3871.60 ng/mL | Standard Error 782.5 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers | TIMP-2-week 3 | 1.43 ng/mL | Standard Error 0.46 |
Differences in Angiogenic Biomarkers: PDGF-BB
Within-subject difference between the concentrations at the CelTX and Free Gingival Graft areas
Time frame: 5 time-points: pre-surgical, week(s) 1, 2, 3 and 4
Population: 44 subjects were enrolled. All 44 subjects participated in both arms/groups for a total of 88 surgical sites. 2 surgical sites of each patient were randomly selected to receive LCC as a donor material in 1 site and a conventional autograft using keratinized tissue from the palate as the donor material at the contralateral site.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| CelTx™ | Differences in Angiogenic Biomarkers: PDGF-BB | Pre-surgical | 10.59 pg/mL | Standard Error 3.06 |
| CelTx™ | Differences in Angiogenic Biomarkers: PDGF-BB | Week 2 | 4.50 pg/mL | Standard Error 3.03 |
| CelTx™ | Differences in Angiogenic Biomarkers: PDGF-BB | Week 3 | 2.15 pg/mL | Standard Error 0.83 |
| CelTx™ | Differences in Angiogenic Biomarkers: PDGF-BB | Week 1 | 51.82 pg/mL | Standard Error 20.41 |
| CelTx™ | Differences in Angiogenic Biomarkers: PDGF-BB | Week 4 | .86 pg/mL | Standard Error 0.43 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers: PDGF-BB | Week 1 | 28.92 pg/mL | Standard Error 13.73 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers: PDGF-BB | Week 2 | 2.33 pg/mL | Standard Error 1 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers: PDGF-BB | Pre-surgical | 9.73 pg/mL | Standard Error 3.41 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers: PDGF-BB | Week 4 | .87 pg/mL | Standard Error 0.5 |
| Free Gingival Grafts | Differences in Angiogenic Biomarkers: PDGF-BB | Week 3 | 1.01 pg/mL | Standard Error 0.44 |